Previously, there has been limited research into the trends and patterns in treatment for patients when they are diagnosed with stage IV cancer, compared to those for early stage cancer.
Katherine Henson is a senior analyst in Public Health England’s National Cancer Registration and Analysis Service. She leads on the delivery of local cancer intelligence to NHS stakeholders in London, and also on the newly acquired primary care prescriptions dataset.
Prior to joining PHE, Katherine worked as a healthcare analyst for BUPA and has completed a PhD at the Clinical Trial Service Unit in the University of Oxford. Her research focused on the long-term risks of heart disease and lung cancer after radiotherapy treatment for cancer, specifically breast and teenage and young adult cancer.
Recently the British Journal of Cancer published a study on the short-term breast cancer survival in England in relation to ethnicity and key tumour characteristics. It shows that the excess mortality among black women with breast cancer is attributable to …
Related content and links
About this blog
The official blog of the UK Health Security Agency, providing expert insight on the organisation's work and all aspects of health security.
Comments and moderation
- Charting a course to end HIV transmission in England by 2030 1 December 2021
- What is avian flu? 26 November 2021
- What is antimicrobial resistance and why do we need to take action against it? 17 November 2021